NOCIL Ltd Q2FY26 – When Rubber Meets Resistance, and Profits Refuse to Bounce Back
1. At a Glance
Once upon a chemical time, NOCIL Ltd (India’s largest rubber chemicals producer and a proud member of the Mafatlal clan) was a market darling — now it’s a tired tyre in the chemical pitstop. With a market cap of ₹3,088 crore, a stock price of ₹185, and a P/E ratio of 49×, the valuation looks more Michelin, less MRF.
Q2FY26 wasn’t pretty. Revenue dipped to ₹321 crore (down 11.6% YoY) while PAT collapsed 71.2% to ₹12.1 crore. Margins, which once strutted around at 20% in good times, are now limping at 7% OPM. EPS? A rubbery ₹0.73, barely covering a decent Vada Pav at a Mumbai café.
Still, the balance sheet is squeaky clean: Debt only ₹10 crore, cash pile large, and a current ratio of 5.8—basically, this company could pay off its debt with loose change from the CFO’s drawer. But with ROE at 5.9% and ROCE at 6.6%, shareholders are left wondering if all that cash should at least be earning compound interest at a bank instead.
The silver lining? They’re expanding Dahej by 20% with a ₹250 crore capex, praying that global rubber demand inflates again before their patience deflates.
2. Introduction – The Bounce That Wouldn’t Bounce
If there were a “Netflix: Chemicals Edition,” NOCIL would be that quiet slow-burn show critics love but audiences skip. Established in 1961, this company manufactures rubber chemicals — accelerators, anti-degradants, antioxidants — basically the invisible backbone that keeps India’s tyres from melting during Delhi summers.
The company dominates India’s rubber chemicals market with a 40% market share, and it exports to 40+ countries, which sounds amazing until you realize exports have been the problem child lately.
After FY22’s high, NOCIL’s fortunes got punctured by global slowdowns, cheap Chinese dumping, and weaker latex demand in Southeast Asia. FY24 saw volumes at 65% capacity utilization — the industrial equivalent of owning a Ferrari and using it to deliver pizza once a week.
Yet, the Mafatlal-led management remains disciplined — zero leverage, steady dividends, and capex optimism. The problem? Demand isn’t matching the enthusiasm.
So here we are: a company that’s financially strong but operationally under-stimulated. Think of NOCIL as the chemical equivalent of that gym-goer who pays for a personal trainer but never shows up.
3. Business Model – WTF Do They Even Do?
In simple terms, NOCIL is the Adda247 of the tyre industry — no glamour, but the entire system collapses without it.
The company manufactures over 20 rubber chemical variants grouped under:
Accelerators – Speed up vulcanization (basically, how rubber gets tougher).
Antioxidants/Anti-degradants – Keep tyres from aging faster than Indian soap opera characters.
Specialty chemicals – Custom compounds for niche rubber products.
Their brands — Pilflex, Pilnox, Pilcure, Pilgard — sound like Pokémon evolutions, but they’re trusted across India’s tyre giants like MRF, Apollo, CEAT, JK Tyre, and more.
Two major plants: Navi Mumbai and Dahej, with a combined capacity of 1,15,000 MTPA. Dahej is their crown jewel — closer to ports, cheaper to expand, and where the ₹250 crore brownfield expansion (20% more capacity) is currently underway.
Their customers test and approve suppliers for 6–18 months, meaning relationships are sticky — but also slow to change. When demand drops, you can’t just pivot to selling antioxidants on Flipkart.
Question for the audience: If you had a monopoly-like position in India but global prices crashing every quarter, would you sit tight or reinvent? NOCIL seems to have chosen meditation over innovation.
4. Financials Overview
Source table
Metric
Q2FY26
Q2FY25
Q1FY26
YoY %
QoQ %
Revenue
₹321 Cr
₹363 Cr
₹336 Cr
-11.6%
-4.5%
EBITDA
₹22 Cr
₹38 Cr
₹31 Cr
-42.1%
-29.0%
PAT
₹12.1 Cr
₹42 Cr
₹17 Cr
-71.2%
-28.8%
EPS (₹)
0.73
2.52
1.03
-71.0%
-29.1%
Commentary: In the chemical world, that’s called a “meltdown.” Revenue slipped, but PAT nosedived harder than Sensex on Budget day. The brutal margin compression (EBITDA down 42%) shows raw material costs stayed high while export pricing power vanished.
P/E of 49×? Let’s call that optimism on steroids — because no one’s paying that multiple for a 6% ROE unless they’re daydreaming about a China-plus-one miracle.
5. Valuation Discussion – Fair Value Range Only
Let’s crunch this one carefully (no, not rubber):
A) P/E Method
Annualized EPS (₹3.8) × Reasonable P/E Range (20–35×) → Fair Value Range: ₹76 – ₹133 per share
